$PNC.US ranked positive on January 25th, 2023

PNC Financial Services Group Inc – (PNC, +1, Jan 25th)  William Demchak (Chairman & CEO since 2014, joined company as CFO in 2002) purchased 6,550 shares on January 20th at $153.38, spending $1,004,639. The trade is both his first purchase since 2009 (which was well-timed) and also a reversal from a sale at a similar […]

Read More

$EOG.US ranked positive on January 18th, 2023

EOG Resources Inc – (EOG, +1, January 18th)  Michael Kerr (Non Executive since 2020) purchased $2.6 million of stock on the 12th January at $130.49, increasing his stake by 12%. His only previous purchase was for $4.3m of stock in November 2021 at $86 which we ranked +N reflecting his likely long history following the […]

Read More

$LOVE.US ranked positive on January 5th, 2023

We did not rank any new stocks this week and therefore are using an upgrade from January 5th, Lovesac (LOVE +N) for the stock of the week. Note that a month ago we downgraded RH (RH -N on Dec. 9th), a much larger and more established competitor but both stocks have had >-60% declines from […]

Read More

$MACK.US ranked positive on January 6th, 2023

Merrimack Pharmaceutical Inc – (MACK, +1, January 4th)  Eric Andersen (Non-Executive since 2019) bought $2.8 million of stock on the 30th of December at $10.67, increasing his stake by 20%. The purchases were indirect and on behalf of Western Standard, they now own 11.4% of the outstanding shares. They made a series of purchases into […]

Read More

$HROW.US ranked positive on December 23rd, 2022

Harrow Health Inc – (HROW, +1, Dec 23rd) Four insiders bought a total of $725,000 of stock on the 21-22nd December at approx $13.40. Most notably Mark Baum (CEO since 2012, founder) bought $325,000 increasing his stake by 2% in his first clean purchase on record despite a long tenure and Martin Makary (Non-Executive since […]

Read More